Changing population of liver transplant recipients in the era of direct-acting antiviral therapy

Keyphrases

• Direct-acting Antivirals 100%
• Liver Transplant Recipients 100%
• Direct-acting Antiviral Therapy 100%
• Liver Disease 50%
• Hepatitis C Virus 40%
• Liver Transplantation 40%
• Nonalcoholic Steatohepatitis 40%
• Hepatocellular Carcinoma 20%
• Diabetic 20%
• Liver Disease Etiology 20%
• Comorbidity 10%
• Immunosuppression 10%
• Hepatitis C Virus Infection 10%
• Chi-square 10%
• Statistical Test 10%
• Young Female 10%
• Retrospective Cohort 10%
• Population Demographics 10%
• Alcoholic Hepatitis 10%
• MELD Score 10%
• Donor Risk Index 10%
• United Network for Organ Sharing 10%
• Recipient Characteristics 10%
• Graft Quality 10%
• Liver Disease Severity 10%
• χ Analysis 10%
• Acute-on-chronic Liver Failure 10%

Medicine and Dentistry

• Antiviral Therapy 100%
• Liver Transplantation 100%
• Liver Graft 100%
• Antivirus Agent 83%
• Liver Disease 66%
• Hepatitis C Virus 33%
• Hepatitis C 8%
• Diabetes Mellitus 8%
• Immunosuppressive Treatment 8%
• Hepatocellular Carcinoma 8%
• Disease Severity 8%
• Alcohol Liver Disease 8%
• Analysis of Variance 8%
• Diabetic Obesity 8%
• Model For End Stage Liver Disease Score 8%
• Acute on Chronic Liver Failure 8%
• Comorbidity 8%
• Noma 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Antivirus Agent 100%
• Antiviral Therapy 100%
• Liver Disease 80%
• Hepatitis C Virus 40%
• Liver Cell Carcinoma 10%
• Hepatitis C 10%
• Diabetes Mellitus 10%
• Alcohol Liver Disease 10%
• Disease Severity 10%
• End Stage Liver Disease 10%
• Diabetic Obesity 10%
• Acute on Chronic Liver Failure 10%
• Comorbidity 10%
• Noma 10%